Epstein-Barr Virus Protein EBNA-LP Engages YY1 Through Leucine-rich Motifs to Promote Naïve B Cell Transformation

Overview

Journal bioRxiv

Date 2024 Jan 23

PMID 38260266

Authors

Jana M Cable

Nicolas M Reinoso-Vizcaino

Robert E White

Micah A Luftig

Affiliations

Soon will be listed here.

Abstract

Epstein-Barr Virus (EBV) is associated with numerous cancers including B cell lymphomas. , EBV transforms primary B cells into immortalized Lymphoblastoid Cell Lines (LCLs) which serves as a model to study the role of viral proteins in EBV malignancies. EBV induced cellular transformation is driven by viral proteins including EBV-Nuclear Antigens (EBNAs). EBNA-LP is important for the transformation of naïve but not memory B cells. While EBNA-LP was thought to promote gene activation by EBNA2, EBNA-LP Knock Out (LPKO) virus-infected cells express EBNA2-activated genes efficiently. Therefore, a gap in knowledge exists as to what roles EBNA-LP plays in naïve B cell transformation. We developed a trans-complementation assay wherein transfection with wild-type EBNA-LP rescues the transformation of peripheral blood- and cord blood-derived naïve B cells by LPKO virus. Despite EBNA-LP phosphorylation sites being important in EBNA2 co-activation; neither phospho-mutant nor phospho-mimetic EBNA-LP was defective in rescuing naïve B cell outgrowth. However, we identified conserved leucine-rich motifs in EBNA-LP that were required for transformation of adult naïve and cord blood B cells. Because cellular PPAR-γ coactivator (PGC) proteins use leucine-rich motifs to engage transcription factors including YY1, a key regulator of DNA looping and metabolism, we examined the role of EBNA-LP in engaging cellular transcription factors. We found a significant overlap between EBNA-LP and YY1 in ChIP-Seq data and confirmed their biochemical association in LCLs by endogenous co-immunoprecipitation. Moreover, we found that the EBNA-LP leucine-rich motifs were required for YY1 interaction in LCLs. Finally, we used Cas9 to knockout YY1 in primary total B cells and naïve B cells prior to EBV infection and found YY1 to be essential for EBV-mediated transformation. We propose that EBNA-LP engages YY1 through conserved leucine-rich motifs to promote EBV transformation of naïve B cells.

References

Zhou H, Schmidt S, Jiang S, Willox B, Bernhardt K, Liang J . Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microbe. 2015; 17(2):205-16. PMC: 4539236. DOI: 10.1016/j.chom.2014.12.013. View

Good K, Avery D, Tangye S . Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol. 2009; 182(2):890-901. DOI: 10.4049/jimmunol.182.2.890. View

Tierney R, Kao K, Nagra J, Rickinson A . Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains. J Virol. 2011; 85(23):12362-75. PMC: 3209410. DOI: 10.1128/JVI.06059-11. View

Price M, Patterson D, Scharer C, Boss J . Progressive Upregulation of Oxidative Metabolism Facilitates Plasmablast Differentiation to a T-Independent Antigen. Cell Rep. 2018; 23(11):3152-3159. PMC: 6092755. DOI: 10.1016/j.celrep.2018.05.053. View

Chang P, Chen L, Shih Y, Tsai P, Liu A, Hung C . Role of the cellular transcription factor YY1 in the latent-lytic switch of Kaposi's sarcoma-associated herpesvirus. Virology. 2011; 413(2):194-204. DOI: 10.1016/j.virol.2011.02.013. View

Seidah N, Wennogle L . Substrate phosphorylation can inhibit proteolysis by trypsin-like enzymes. Arch Biochem Biophys. 1989; 272(2):274-80. DOI: 10.1016/0003-9861(89)90220-8. View

Yoo L, Woloszynek J, Templeton S, Speck S . Deletion of Epstein-Barr virus regulatory sequences upstream of the EBNA gene promoter Wp1 is unfavorable for B-Cell immortalization. J Virol. 2002; 76(22):11763-9. PMC: 136791. DOI: 10.1128/jvi.76.22.11763-11769.2002. View

Alfieri C, Birkenbach M, Kieff E . Early events in Epstein-Barr virus infection of human B lymphocytes. Virology. 1991; 181(2):595-608. DOI: 10.1016/0042-6822(91)90893-g. View

SoRelle E, Dai J, Reinoso-Vizcaino N, Barry A, Chan C, Luftig M . Time-resolved transcriptomes reveal diverse B cell fate trajectories in the early response to Epstein-Barr virus infection. Cell Rep. 2022; 40(9):111286. PMC: 9879279. DOI: 10.1016/j.celrep.2022.111286. View

10.

Nandi S, Liang G, Sindhava V, Angireddy R, Basu A, Banerjee S . YY1 control of mitochondrial-related genes does not account for regulation of immunoglobulin class switch recombination in mice. Eur J Immunol. 2020; 50(6):822-838. PMC: 8287517. DOI: 10.1002/eji.201948385. View

11.

Good K, Tangye S . Decreased expression of Kruppel-like factors in memory B cells induces the rapid response typical of secondary antibody responses. Proc Natl Acad Sci U S A. 2007; 104(33):13420-5. PMC: 1948953. DOI: 10.1073/pnas.0703872104. View

12.

Babcock G, Decker L, Volk M, Thorley-Lawson D . EBV persistence in memory B cells in vivo. Immunity. 1998; 9(3):395-404. DOI: 10.1016/s1074-7613(00)80622-6. View

13.

Weintraub A, Li C, Zamudio A, Sigova A, Hannett N, Day D . YY1 Is a Structural Regulator of Enhancer-Promoter Loops. Cell. 2017; 171(7):1573-1588.e28. PMC: 5785279. DOI: 10.1016/j.cell.2017.11.008. View

14.

Sinclair A, Palmero I, Peters G, Farrell P . EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 1994; 13(14):3321-8. PMC: 395229. DOI: 10.1002/j.1460-2075.1994.tb06634.x. View

15.

Kitay M, Rowe D . Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP. J Virol. 1996; 70(11):7885-93. PMC: 190860. DOI: 10.1128/JVI.70.11.7885-7893.1996. View

16.

Heery D, Kalkhoven E, Hoare S, Parker M . A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 1997; 387(6634):733-6. DOI: 10.1038/42750. View

17.

Poole E, Carlan da Silva M, Huang C, Perera M, Jackson S, Groves I . A BMPR2/YY1 Signaling Axis Is Required for Human Cytomegalovirus Latency in Undifferentiated Myeloid Cells. mBio. 2021; 12(3):e0022721. PMC: 8262994. DOI: 10.1128/mBio.00227-21. View

18.

Green M, Monti S, Dalla-Favera R, Pasqualucci L, Walsh N, Schmidt-Supprian M . Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program. Proc Natl Acad Sci U S A. 2011; 108(7):2873-8. PMC: 3041080. DOI: 10.1073/pnas.1019537108. View

19.

Chang L, Liu S . Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation. Nucleic Acids Res. 2000; 28(20):3918-25. PMC: 110796. DOI: 10.1093/nar/28.20.3918. View

20.

Banerjee A, Sindhava V, Vuyyuru R, Jha V, Hodewadekar S, Manser T . YY1 Is Required for Germinal Center B Cell Development. PLoS One. 2016; 11(5):e0155311. PMC: 4863967. DOI: 10.1371/journal.pone.0155311. View